Table of Contents
Definition / general | Terminology | Epidemiology | Sites | Prognostic factors | Clinical images | Microscopic (histologic) description | Microscopic (histologic) images | Positive stains | Differential diagnosis | Additional referencesCite this page: Neuroendocrine carcinoma. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/colontumorneuroendocrine.html. Accessed July 14th, 2017.
Definition / general
- Rare, high grade neuroendocrine malignancy of the colorectum with poor prognosis (Am J Surg Pathol 2008;32:719)
- Excludes well differentiated neuroendocrine tumors (also known as carcinoid tumors)
Terminology
- Two types, based on morphology: large cell neuroendocrine carcinoma (discussed herein) and small cell carcinoma (discussed here)
Epidemiology
- Disease typically presents at advanced stage, in patients often younger than those with colorectal adenocarcinoma (Dis Colon Rectum 2004;47:163)
Sites
- Can arise anywhere along the colon or rectum
Prognostic factors
- Good prognostic factors include peritumoral lymphocytes, microsatellite instability and pure large cell features; poor prognostic factors include CD117 positivity and vascular invasion (Am J Surg Pathol 2012;36:601)
Microscopic (histologic) description
- Organoid arrangement of cells larger than those in small cell carcinoma, with nuclear pleomorphism and hyperchromasia, prominent nucleoli, numerous mitoses and tumor necrosis
Microscopic (histologic) images
Positive stains
- Cytokeratin, synaptophysin, chromogranin; high Ki67 index
- CD117 in 23%, though not associated with activating mutations (Am J Surg Pathol 2003;27:1551)
Differential diagnosis
- Mixed adenoneuroendocrine carcinoma (MANEC): tumors with neuroendocrine and adenocarcinoma components of at least 30% each (Cancers (Basel) 2012;4:11)
- Adenocarcinoma with scattered neuroendocrine cells: common; histology resembles traditional colorectal adenocarcinoma (Arch Pathol Lab Med 1998;122:912)










